PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
24.72%
Revenue growth of 24.72% while 8198.HK is flat. Bruce Berkowitz would check if a small edge can widen further.
-76.02%
Negative gross profit growth while 8198.HK is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-56.61%
Negative EBIT growth while 8198.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-38.79%
Negative operating income growth while 8198.HK is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-32.02%
Negative net income growth while 8198.HK stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-32.52%
Negative EPS growth while 8198.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-32.52%
Negative diluted EPS growth while 8198.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share change of 0.00% while 8198.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
OCF growth of 100.00% while 8198.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
100.00%
FCF growth of 100.00% while 8198.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-94.79%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-72.16%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-8.24%
Negative 3Y CAGR while 8198.HK stands at 70.15%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Negative 10Y OCF/share CAGR while 8198.HK stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
100.00%
3Y OCF/share CAGR similar to 8198.HK's 100.00%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
-312.21%
Negative 10Y net income/share CAGR while 8198.HK is at 61.79%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-557.81%
Negative 5Y net income/share CAGR while 8198.HK is 82.77%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
20.57%
Below 50% of 8198.HK's 95.58%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-55.77%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-54.84%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-48.30%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-52.48%
Firm’s AR is declining while 8198.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-13.61%
Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-13.92%
We have a declining book value while 8198.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-34.53%
We’re deleveraging while 8198.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
97.32%
R&D growth of 97.32% while 8198.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
3.37%
SG&A growth of 3.37% while 8198.HK is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.